A population-based study revealed treatment patterns among patients starting chemotherapy as first-line therapy for ...

Olverembatinib demonstrated activity in patients with CP-CML who received first- or second-generation TKIs as first-line therapy.

T-DXd outperformed physician’s choice of chemotherapy regardless of patients’ disease burden or time to progression on prior therapy.

Erectile dysfunction (ED) and testosterone deficiency (TD) are more common among men with testicular cancer, a new study finds. In a study of US male veterans, investigators matched 1754 patients with ...

A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study published online Jan. 8 in npj Digital Medicine. Noting there are no personalized ...